Nektar Therapeutics

Ownership Transactions Reported by 15 Insiders

Symbol
NKTR on Nasdaq
Location
455 Mission Bay Boulevard South, San Francisco, CA

Insiders trading volume in the past year

Nektar Therapeutics executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Deep Track Capital, LP 10%+ Owner $32.6M -$99.6K -0.3% May 10, 2024
Howard W. Robin President & CEO, Director $1.09M -$71.5K -6.18% Aug 19, 2024
Jonathan Zalevsky Chief R&D Officer $321K -$32.5K -9.2% Aug 19, 2024
Robert Chess Director $311K -$23.4K -6.99% Jun 14, 2024
Mark A. Wilson Chief Legal Officer $288K -$26.9K -8.53% Aug 19, 2024
Jillian B. Thomsen Chief Financial Officer $154K Feb 16, 2023
Gil M. Labrucherie Svp, Coo & Cfo $153K May 15, 2022
John Northcott SVP & Chief Commercial Officer $109K May 16, 2022
Jeffrey Robert Ajer Director $16.7K Sep 18, 2023
Curet Myriam Director $13.4K Sep 18, 2023
Karin Eastham Director $11.4K Sep 16, 2022
Sandra A. Gardiner Chief Financial Officer Apr 17, 2023
Diana Brainard Director Sep 19, 2023
R. Scott Greer Director Sep 19, 2023
Roy A. Whitfield Director Sep 19, 2023

Recent Insider Transactions by Companies or Individuals for Nektar Therapeutics

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.